(Philadelphia, PA) – Alzheimer’s disease is the most common form of dementia in the elderly. Memory loss and difficulty thinking worsen progressively, with some patients eventually becoming delusional, disoriented, and vulnerable to mood swings and depression. Finding ways to slow or reverse this progression, or even prevent symptoms from developing in the first place, are major goals in Alzheimer’s research.
Now, thanks to a new $3.8 million grant from the Pennsylvania Department of Health, researchers at the Alzheimer’s Center at Temple (ACT) will have an unprecedented opportunity to explore cardiovascular risk factors in Alzheimer’s disease. The grant is the first major collaborative award for the Alzheimer’s Center at